Caris Life Sciences Inc

CAINASDAQ · USD
25.23USD-0.80 (-3.08%)
3310

Caris Life Sciences Inc (CAI) Option Chain

Caris Life Sciences Inc trades at $25.23, down 3.08%, with an IV Rank of 75.00%. This is high versus the past year, and the company carries a market cap of $7,356M in the Biotechnology industry. On the Nov 20, 2026 chain, the at the money $25.00 strike shows calls at $0.50 / $4.10 and puts at $0.75 / $2.00, both carrying about $1.72 of extrinsic value and a roughly 50% probability of expiring out of the money. Volume is heaviest on the $35.00 calls, at 186 contracts, and the $25.00 puts, at 128, as of Nov 5, 2026.

Read more

Tracking the CAI option chain helps you see every strike and expiry on Caris Life Sciences Inc in one view, so you can quickly identify contracts that fit your thesis and your risk. It lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of CAI options activity at a glance. Use our scanner to monitor the CAI option chain in real time and filter for the trades that actually meet your criteria.

An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For CAI stock options, the chain shows call and put data side by side, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading it well means looking beyond the last price. Implied volatility by strike, volume to open interest ratios, and bid ask spreads all show where CAI options are being actively traded, and where they are not.

Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and machine learning algorithms. The company's molecular profiling services portfolio includes MI Profile, a tissue-based molecular profiling solution; and Caris Assure, a blood-based molecular profiling solution for cancer treatment. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers.

2026-11-20
5 strikes
Default
CALLsPUTs
Prob. OTM %Open InterestVolumeExtrinsic ValueIntrinsic ValueBidAskStrikeMoneyness %BidAskIntrinsic ValueExtrinsic ValueVolumeOpen InterestProb. OTM %
2.75001.127.736.9010.8017.50-32.77—2.150.002.150097.25
10.693601.225.234.508.4020.00-23.17—0.250.000.250089.31
25.882001.552.732.356.2022.50-13.56—2.550.002.550074.12
45.471542.070.230.504.1025.00-3.960.752.000.001.3812826654.53
79.07279730.600.000.201.0030.00+15.253.806.404.770.3397320.93

As of Nov 5, 2026

Prices move. This one stays.Lock in 5 years at a special price and save $2,243. Ending soon.See the Early Bird Black Friday deal →

Stock Statistics

  • IndustryBiotechnology
  • SectorHealthcare
  • IV Rank75.00% High
  • Market cap (M$)7,356
  • 52 weeks high-28.68%
  • 52 weeks low83.44%
  • Analyst recommendationBuy
    1.64
  • Target price$33.38
    28.66% above the current stock price
  • Dividend—
  • Payout ratio—
  • Earnings date2026-11-04
  • P/E77.08
  • Future P/E80.16
  • EPS (ttm)0.34
  • EPS growth next 5 years—

As of Nov 5, 2026